MALAT1 and neoplasm: However, the inclusion of a miR-22-3p inhibitor in the MALAT-1 shRNA-treated tumor cells significantly reversed the inhibitory effect of MALAT-1 shRNA on the expression of p-PI3K and p-Akt.